A peptide called MOTS-c has shown promise in preventing type 1 diabetes, according to new tests in human cells in culture and live mice. The peptide seems to regulate the immune system ...

The C-peptide test helps your doctor identify whether you have type 1 diabetes (when the immune system attacks and destroys cells in the pancreas) or type 2 diabetes (when your body doesn't use ...

Whether baricitinib preserves β-cell ... of type 1 diabetes within 100 days before starting baricitinib or placebo, the presence of at least one islet autoantibody, and either a random C-peptide ...

One challenge of using cell therapy to treat type 1 diabetes is that this approach ... this open-label study was to measure the change in C-peptide, a peptide that is released along with insulin.

A study published in Diabetes Care has revealed that children with acute recurrent or chronic pancreatitis who test positive ...

Whether improved glucose control with hybrid closed-loop therapy can preserve C-peptide secretion as compared with standard insulin therapy in persons with new-onset type 1 diabetes is unclear.

Vertex is ending work on one of its two clinical-stage islet cell treatments ... an increase in peak C-peptide—a biomarker of insulin production—in individuals with Type 1 diabetes during ...

Researchers have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver cancer and cirrhosis. Researchers from UCLA's ...

All 12 patients who received the full dose of VX-880 as a single infusion demonstrated islet cell engraftment ... B and C of the trial are consistent with previously reported positive results ...